BAM Logo

POCT Cardiac

[POCT Cardiac]

EPTIS factsheet 1176672 | Last revision 2024-05-22 | URL: https://www.eptis.bam.de/pts1176672 https://www.eptis.bam.de/pts1176672

PT provider
PT provider Weqas Weqas
Based in United Kingdom
Remarks Three liquid human plasma samples are distributed monthly, with a minimum of 36 samples distributed over the year covering a wide clinical range. The samples consist of a panel of linearly related samples produced from heparin plasma donations from healthy volunteers spiked with Cardiac Troponin complex, Myoglobin, and the MB isoenzyme of Creatine Kinase (CKMB). The programme includes samples that span the analytical and clinically relevant ranges. The programme accommodates POCT assays reporting quantitative and qualitative results. They are distributed on a number of occasions over the year, which allows for the assessment of the organisation’s and method’s performance, including linearity, bias, within and between batch imprecision. Key Features: - EDTA plasma samples require no pre-analytical preparation. - Linearly related panel covering a clinically relevant range. For more information: https://www.weqas.com/services/poct-eqa/poct-cardiac/ or contact@weqas.com For information on hsTroponin https://www.weqas.com/services/eqa/hs-troponin/ or contact@weqas.com
Product groups Health care / medical devices
Testing fields Medical analysis
Technical details
Test item Tested property Testing method
EDTA plasma Troponin T Routine testing methods (recommended)
Troponin I Routine testing methods (recommended)
CK MB (activity) Routine testing methods (recommended)
CK MB (mass) Routine testing methods (recommended)
Myoglobin Routine testing methods (recommended)
Aims of the PT scheme
Target group of participants The Programme aims to assess the performance of organisations utilising Point of Care tests (POCT) biochemical cardiac markers to aid in the assessment of acute coronary syndrome (ACS) and cardiac ischaemia. A separate programme is available for High sensitivity cardiac Troponin T and I.
Linked to specific legislation / standards Accreditation by UKAS based on ISO/IEC 17043.
Additional, subsidiary aims validation of testing methods
Number of participants
Accredited or otherwise reviewed by a 3rd party

Accredited by UKAS on the basis of ISO/IEC 17043 for part of the parameters

Operation is commissioned / requested by
Fees and frequency
Participation fee https://www.weqas.com/participantzone/subscription-charges/
Regularly operated Yes (Frequency: Monthly. Samples: 3 x 0.5mL. )
Year of first operation 2005
Contact details of the PT provider
Provider Contact person
Unit 6, Parc Ty Glas
CF14 5DU Cardiff
United Kingdom

Phone: 44 (0) 2920 314750
Web: http://www.weqas.com http://www.weqas.com
Laura Lloyd-Lewis
Phone: 44 (0) 29218 32884
Email: laura.lloyd-lewis@wales.nhs.uk laura.lloyd-lewis@wales.nhs.uk
If you find any mistakes please contact the responsible EPTIS coordinator in United Kingdom, Mr Savvas Xystouris. Mr Savvas Xystouris.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5